Design Therapeutics, Inc. DSGN
10.77 USD +0.12 (+1.13%)
At closeNov 11, 2026, 4:00 PM EST
10.77 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
10.44 Day range 10.98
6.81 52-week range 17.25
- YTD
- +14.82%
- 1 year
- +38.79%
News
benzinga.com RBC Capital Maintains Outperform on Design Therapeutics, Lowers Price Target to $19 RBC Capital analyst Leonid Timashev maintains Design Therapeutics (NASDAQ:DSGN) with a Outperform and lowers the price target from $20 to $19.
benzinga.com Design Therapeutics Q3 EPS $(0.32) Beats $(0.35) Estimate Design Therapeutics (NASDAQ:DSGN) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.35) by 8.57 percent. This is a 6.67 percent decrease over losses of…
